Research location

Bodø

Norway

Published trials51

Site observations53

Linked trials published51

Page1 / 2

Research activity in Bodø

Norway

CureCurrent currently publishes aggregate city-level research activity for this location: 51 trials and 53 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Bodø

51 linked trials · page 1 of 2

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation

DESTINY Breast Respond HER2-(Ultra)Low EuropeNCT05945732 · 2023-10-24 · 1 site observation

The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.NCT05634889 · 2023-03-17 · 1 site observation

Partial Breast Versus no Irradiation for Women With Early Breast CancerNCT03646955 · 2018-09-05 · 1 site observation

Biological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineNCT07832032 · 2026-09-17 · 1 site observation

NOT_YET_RECRUITING

Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)NCT06440629 · 2024-08-20 · 1 site observation

ACTIVE_NOT_RECRUITING

Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)NCT06122961 · 2023-11-23 · 1 site observation

A Measurement Study of TIS-modNV and AccuGait Force Platform in People With MSNCT05503628 · 2022-08-15 · 1 site observation

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecNCT05352815 · 2022-06-01 · 1 site observation

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCNCT05211895 · 2022-02-18 · 1 site observation

ACTIVE_NOT_RECRUITING

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung CancerNCT05223647 · 2022-01-11 · 1 site observation

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsNCT05166889 · 2022-01-03 · 1 site observation

Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility StudyNCT05057338 · 2021-08-27 · 2 site observations

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS DiseaseNCT04578639 · 2020-11-02 · 1 site observation

ACTIVE_NOT_RECRUITING

The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology StudyNCT04122235 · 2019-11-18 · 1 site observation

Pragmatic Randomized Control Trial of Telehealth vs Standard Care in Follow-up of Patients With Chronic ConditionsNCT04142710 · 2019-02-09 · 1 site observation

PALLiON - PALLiative Care In ONcologyNCT03088202 · 2017-03-22 · 1 site observation

The Norwegian Drug Monitoring StudyNCT03074656 · 2017-03-01 · 1 site observation

A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusNCT02501161 · 2016-01-31 · 1 site observation

Innovative Physiotherapy and Coordination of Care for People With MS: a RCT and a Qualitative StudyNCT02522962 · 2015-09-01 · 1 site observation

Effectiveness of "Medisinstart"NCT02261402 · 2014-10-01 · 1 site observation

The NOR-SWITCH StudyNCT02148640 · 2014-10-01 · 1 site observation

The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on TiotropiumNCT01899742 · 2014-09-15 · 1 site observation

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02164513 · 2014-06-30 · 1 site observation

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02155660 · 2014-06-25 · 1 site observation

Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT02105948 · 2014-04-15 · 1 site observation

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerNCT02106546 · 2014-04-10 · 1 site observation

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild SymptomsNCT02043678 · 2014-03-30 · 1 site observation

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 2 site observations

Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation

A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01879410 · 2013-06-13 · 1 site observation

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNCT01618370 · 2012-07-22 · 1 site observation

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDNCT01313637 · 2011-03-01 · 1 site observation

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)NCT01147250 · 2010-06-01 · 1 site observation

Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization StudyNCT01110200 · 2010-04-30 · 1 site observation

Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal CancersNCT01023529 · 2009-11-01 · 1 site observation

Thiazolidinedione Intervention With Vitamin D EvaluationNCT00879970 · 2009-05-01 · 1 site observation

European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation

Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMSNCT00884481 · 2009-03-23 · 1 site observation

The Impact of Preoperative Breast MRI in Patients With Breast Cancer Selected for Breast Conserving SurgeryNCT01391806 · 2009-01-01 · 1 site observation

A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal MetastasesNCT00699751 · 2008-06-12 · 1 site observation

Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation

GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateNCT00261352 · 2005-03-01 · 1 site observation

Metformin in Pregnant PCOS WomenNCT00159536 · 2005-02-01 · 1 site observation

MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and AdultsNCT00242411 · 2004-09-01 · 1 site observation

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseNCT00099242 · 2003-11-01 · 1 site observation

EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With TolvaptanNCT00071331 · 2003-09-01 · 1 site observation

Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesNCT00312156 · 2002-08-01 · 1 site observation

Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00268216 · 2000-09-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.